Authors: Bevers LAH, Kamphuis AEM, van der Wekken-Pas LC, Leisegang R, Lewis L, Burger DM, Colbers A Presented at: International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023 [button...
Musakanya Chingandu
Gilead Partners with CHAI and Penta to Improve Treatment and Adherence Rates Among Children with HIV in Low and Middle Income Countries
- Partnership Aims to Accelerate the Development of Dispersible Pediatric HIV Medicines - FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) is pleased to announce two public-private partnerships. The first will accelerate the...
Inaugural training session for the Clinical Trial Management course
The inaugural Clinical Trial Management training program took place online on Wednesday, 14 June 2023, after 428 participants registered. The session was well attended by up to 168 clinical trial staff representing 30 countries. The training course is being...
UNIVERSAL General Assembly Meeting 2023
The UNIVERSAL General Assembly meeting was held from 22 to 24 May 2023, in Harare, Zimbabwe. The UNIVERSAL project aims to develop two antiretroviral fixed-dose combinations for infants and children newly diagnosed with HIV. These formulations will also benefit...
Get to know the UNIVERSAL project: Relative Bioavailability study (PK sub-study)
Welcome to the “Get to know the UNIVERSAL project” series! Here we will introduce you to the various work packages and facets that make up the UNIVERSAL project. The UNIVERSAL-Relative Bioavailability (RBA) sub-study will inform the UNIVERSAL 1 trial which aims to...
Get to know the UNIVERSAL project: Pharmacokinetic study of new DTG FTC TAF dose ratio
Welcome to the of the “Get to know the UNIVERSAL project” series! Here we will introduce you to the various work packages and facets that make up the UNIVERSAL project. Pharmacokinetic study of new DTC, FTC, TAF dose ratio (Work package 3) Within the...
Get to know the UNIVERSAL project: Assessing the long-term safety of ART drugs
Welcome to the “Get to know the UNIVERSAL project” series! Here we will introduce you to the various work packages and facets that make up the UNIVERSAL project. Assessing the long-term safety of ART drugs (Work package 5) Prompt treatment of children living...
Caroline Angel Nansubuga
Current position: I am a postgraduate student pursing a master’s degree of Medicine in Pediatrics and Child health. Research area: I aim to describe the magnitude and factors associated with poor health related quality of life among adolescents living with HIV. Award:...
Nakamyuka Rashidah
My name is Nakamyuka Rashidah and I’m currently pursuing a Master’s degree in Pharmacology at Makerere University. So far as a beneficiary of the Universal Capacity Building Project, I have had the privilege of attending a training on the Application of...
Dr Daniel Kesseng Kiyeck
I am doctor Daniel Kesseng Kiyeck, born on 11th august 1989, in Yaoundé, Country: Cameroon. Professional background: I obtained my medical degree at ‘Université des Montagnes’ of Bangangté Cameroon in 2015, then my master degree in public health at the Catholic...